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Abstract 
 
The investigation of the effects of nanotechnology on the quality of life of the 
population through level-headed consults to specialists will allow answering 
relevant questions about environmental effects of nanotechnology and about 
the use and destination of its products and wastes. We present herein a method 
for assessing an index of nanotechnology safety based technical parameters. 
This methodology includes validating the indicators and methods created based 
on the advice of specialists in nanotechnology and related areas. Therefore, the 
development of a new approach to assess the safety of the nanotechnologies is 
an effective mitigatory measure to face the growing challenges pointed out by 
scientists and legislators concerning environmental degradation, ethical and 
social issues. The present study aims at creating a methodology for safety 
assessment of nanotechnologies based on technical data on technology usage 
from the literature. Those data could be used as a guide to ex ante or ex post 
evaluations of nanotechnology uses and their effects on the environment.  
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Introduction 
 
Nanotechnology is a technology which is indeed widely accepted but not 
when it is linked to food, and that the attitude to nanotechnology is driven by 
determinants other than knowledge. Hence, for targeted risk communication it 
is important to develop strategies that help people to comprehend 
nanotechnology, to differentiate between the fields of application and to gain 
an understanding of the cause and effect chains (Simons et al., 2009). 
In addition, most previous studies that have focused on the regulation of 
nanotechnology have used descriptive analyses or have tended to focus on 
normative suggestions for adapting or reforming the existing regulation system. 
The novel attributes of nanotechnology demand different routes for risk-benefit 
assessment and risk management, and at present, nanotechnology innovation 
proceeds ahead of the policy and regulatory environment. Nanoscale structures 
and nanosystems have the potential to affect not only human health and the 
environment but also aspects of social lifestyle, human identity and cultural 
values. The main recommendations for risk-benefit assessment and risk 
management deal with selected higher risk nanotechnology applications, short- 
and long-term issues, and global models for nanotechnology governance (Renn 
& Roco, 2006). 
Policy discussions about the social, political, and ethical implications 
nanotechnology remain limited. There is a high degree of scientific uncertainty 
about the risks of nanotechnology. In the absence of risk assessment data, 
decision makers often rely on scientists’ input about risks and regulation to 
make policy decisions. Only recently have social scientists and policy-makers 
started to pay attention to the social dimensions of nanotechnology research, 
particularly within the context of how we might regulate it (Corley et al., 
2009).  
The understanding of potentially risky situations is increasingly multifaceted, 
which again challenges risk assessors in terms of giving the ‘right’ relative 
priority to the multitude of contributing risk factors. Some models were 
proposed to evaluate nanoproducts. One of them Worst Case Definition 
(WCD) model, to set up and evaluate the conditions of multi-dimensional risk 
identification and risk quantification. The model can help optimize risk 
assessment planning by initial screening level analyses and guiding 
quantitative assessment in relation to knowledge needs for better decision 
support concerning environmental and human health protection or risk 
reduction. The conceptual Worst Case Definition (WCD) model is suggested as 
a tool that can address the problem of ignorance related to the definition of 
worst case conditions for risk management of chemicals and nanomaterials. 
The model focuses on the uncertainty related to the context and concept behind 
the risk assessment. The two key elements in the method define what to protect 
in terms of Protected Units (PUs) and how to assess in terms of the Causes of 
Risk (CRs), respectively (Sørensen et al., 2010). 
No clear consensus was reached regarding the classification of nanomaterials 
into categories to aid environmental studies, except that a chemistry-based 
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classification system was a reasonable starting point, with some modifications. 
It was suggested, that additional work may be required to derive criteria that 
can be used to generate such categories that would also include aspects of the 
material structure and physical behavior. The physicochemical characterization 
information identified as important for environmental studies included 
measures of aggregation/agglomeration/dispersability, size, dissolution 
(solubility), surface area, surface charge, surface chemistry/composition, with 
the assumption that chemical composition would already be known. It was also 
emphasized that the measurement of specific properties, via certain techniques, 
will sometimes generate an important set of data, rather than an individual 
value, within the same analysis. Therefore, it is not possible, or desirable, to list 
a complete or appropriate set of properties that needs to be characterized for 
each study, without a definition of the aim of the research. In addition 
properties should be characterized in the test system and not in “the bottle” in 
which they were supplied. 
The prioritization of properties to be determined also implies the need to 
attach available and suitable methods to measure these properties. 
Unfortunately this is not always possible, for example, there is no method 
available to directly measure the specific surface area in an aqueous dispersion 
of particles. Another relevant example is that there is a high risk of producing 
biased results with the different sizing techniques available. Environmental 
matrices such as surface water and soil differ widely in pH and ionic 
composition, thus agglomeration/aggregation and adsorption, and in turn 
mobility in the environment, may be predicted if pH dependent stability is 
described. Similarly, studies on nanomaterial translocation within organisms 
can also benefit from pH dependent characteristics, as it is well known that pH 
within an organism varies between organs, tissues and cellular compartments. 
There is still a deficit of information about how far the limitations of the 
different methods may influence the correct interpretation of test results, which 
means that the methods of characterisation and the data interpretation are 
sometimes a matter of debate (Stone et al., 2010). 
Before starting any nanotoxicological study, it is imperative to know the state 
of the nanoparticles to be used and in particular their size and size distribution 
in the appropriate test media is particularly important. Particles satisfying 
standards can be commercially purchased; however, these invariably cannot be 
used directly and need to be dispersed into the relevant biological media. Often 
such changes in the environment or ionic strength, or a change in the particle 
concentration, results in some aggregation or a shift in the particle size 
distribution. Such unexpected aggregation, dissolution or plating out, if 
unaccounted for, can have a significant effect on the available nanoparticle 
dose and on interpretation of any results obtained thereafter (Montes-Burgos et 
al., 2010).  
The Royal Society of Chemistry suggested that 100 nm is the cut-off above 
which nanoparticles will not enter cells via receptor mediated processes (Royal 
Society of Chemistry and Royal Academy of Engineering, 2005), and some 
experimental evidence corroborating this size as a rough guide is emerging 
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(Chithrani & Chan 2007; Clift et al., 2008). Other important size cut-offs are 
that particles less than 40 nm can enter the nucleus, while particles less than 35 
nm can potentially cross the protective epithelial barriers, such as the blood–
brain barrier (Oberdorster et al., 2004). One should be aware that the real size 
cut-offs are dependent on the material and surface details, and these values are 
at best only guidelines. 
Changes in ionic strength and charge screening, or binding of proteins and 
other biomolecules to the nanoparticles surface can alter their stability in 
dispersion, leading to partial aggregation, and altered (unknown) concentration 
of dispersed nanoparticles. Aggregated particles (where the aggregates are 
long-lived) are no longer available for uptake by cells, and as such, meaningful 
exposure doses cannot be determined, making dose–response curves unreliable. 
In addition, many of the commercially available particles differ significantly in 
terms of their physical properties compared to those specified by the 
manufacturers (Lundqvist et al., 2008). Thus, poorly characterized samples 
have the potential to lead to, at best, confusing and, at worst, misinterpreted 
results. Assessing the potential biological impacts of nanomaterials has become 
of enormous importance in recent years, as the rapid pace of development of 
nanotechnology has not been matched by a complete investigation of their 
safety. The same properties that make nanoparticles exciting for applications, 
namely their small size, their enormous surface area and their high reactivity, 
also make them accessible to previously inaccessible locations in living 
systems with potentially significant consequences for nanomedicine and 
nanosafety. The large surface area means that they bind proteins and other 
biomolecules from biological solutions with great efficiency, and with much 
higher specificity than flat surfaces of equivalent materials (Cedervall et al., 
2007). Thus, characterization of the nanoparticle dispersion in the relevant test 
media is crucial in order to understand the nature of the dispersion actually 
being presented to the cells, tissue, or organism. 
Particles with equivalent diameters below 100 nm are generally distinguished 
into intentionally produced nanoparticles and ubiquitous ultrafine particles. 
The literature generally consider as nanomanufactured, particles with diameters 
≤100 nm, independent of their source.  
The rapid growth in the use of in vitro methods for nanoparticle toxicity 
assessment has proceeded with limited consideration of the unique kinetics of 
these materials in solution. Particles in general and nanoparticles specifically, 
diffuse, settle, and agglomerate in cell culture media as a function of systemic 
and particle properties: media density and viscosity and particle size, shape, 
charge and density, for example. When rates of diffusional and gravitational 
particle delivery are accounted for, trends and magnitude of the cellular dose as 
a function of particle size and density differ significantly from those implied by 
concentration doses. The simple surrogates of dose can cause significant 
misinterpretation of response and uptake data for nanoparticles in vitro. 
Incorporating particokinetics and principles of dosimetry would significantly 
improve the basis for nanoparticle toxicity assessment, increasing the 
predictive power and scalability of such assays (Teeguarden et al., 2007). 
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Environmental impact assessments of engineered nanoparticles require 
thorough characterization of nanoparticles and their aggregates. Furthermore, 
quantitative analytical methods are required to determine environmental 
concentrations and enable both effect and exposure assessments. Many 
methods still need optimization and development, especially for new types of 
nanoparticles in water, but extensive experience can be gained from the fields 
of environmental chemistry of natural nanomaterials and from fundamental 
colloid chemistry (Hassellov et al., 2008).  
Detailed investigations of absorption, distribution, metabolism and excretion 
remain to be performed on species from the major phyla, although there are 
some data on fish. The environmental risk assessment of nanomaterials could 
be performed using the existing tiered approach and regulatory framework, but 
with modifications to methodology including chemical characterization of the 
materials being used (Handy et al., 2008).  
There are areas of considerable uncertainty associated with characterization 
of nanoparticle exposure in test systems that apply to all ecotoxicity testing 
guidelines, except those in which dosing of nanoparticles is oral. These include 
the way in which the substance is dosed into, and maintained within, the test 
medium; measurement and characterization of nanoparticles in the test system; 
better understanding and reporting of abiotic factors that influence behavior of 
nanoparticles in the test medium; and agreement on how dosimetric data 
should be reported (Crane et al., 2008).  
A set of rapid, cost-effective tests should be agreed between regulators, 
industry and other stakeholders that are primarily able to demonstrate that a 
nanoparticle has similar hazard properties to other physical forms of a 
substance. These might include overall toxicity (e.g., cell viability assay or 
microbial population growth test to check for specific modes of toxicity that 
may not be detected by a general toxicity screen, but are relevant for that type 
of nanoparticle, genotoxicity, immunotoxicity assays, and an oxidative stress 
assay. A main aim of rapid tests is to establish whether hazard data on 
demographic endpoints can be read across to nanoparticles from other 
substances—particularly from macroscale substances to their nano-scale 
equivalent. If rapid tests are unable to demonstrate that a nanoparticle has 
similar properties to other physical forms, the demographic effects (survival, 
growth and reproduction) of that nanoparticle should be measured and should 
involve both acute and chronic tests on nanoparticle effects until sufficient 
confidence has been built in the use of assessment factors to extrapolate from 
acute to chronic effects (Crane et al., 2008).  
According some authors (Crane et al., 2008), research on establishing 
appropriate ecotoxicity test strategies and methods for nanoparticles should 
focus primarily on defining realistic worst-case exposure scenarios for 
nanoparticles in the environment and then testing the toxicity of nanoparticles 
under these scenarios. However, the worst case sometimes not reflects the 
reality and some potential technology may be not considered to be 
commercially used based on these results. 
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Therefore, the development of a new approach to assess the safety of the 
nanotechnologies is an effective mitigatory measure to face the growing 
challenges pointed out by scientists and legislators concerning environmental 
degradation, ethical and social issues. The present study aims at creating a 
methodology for safety assessment of nanotechnologies based on technical 
data on technology usage from the literature. Those data could be used as a 
guide to ex ante or ex post evaluations of nanotechnology uses and their effects 
on the environment.  
 
 
Results & Discussion 
 
Nanotechnologies and the Safety-Nanotec Method 
 
The safety assessment of nanotechnology can be a helpful tool in the 
decision-making process. Search engines and systemized data compression 
tools, which allow the generation of traceable conclusions, are key elements to 
assure that the decision-making process culminates in appropriate 
nanotechnology management, with the best resources and results. The present 
study proposes a methodological system to evaluate the nanotechnologies 
safety, providing information organized according to technical parameters from 
several areas where the effects can be directly or indirectly perceived. The 
proposed method is based on validated issues or analysis parameters described 
in previous reports and scientific papers were also considered. The Safety-
Nanotec Method allows the evaluator to choose specific parameters to evaluate 
his/her nanotechnology, what enables the analysis of each particular case.   
Therefore, the nano product or research can be applied in a responsible and 
sensible way. The information is organized in five analyses: (1) Safety data of 
the nano product (A); (2) Residual characterization and destination (B); (3) 
Toxicological characteristics or assessment of the nano product (C); (4) Nano 
product characteristics (D); (5) Risk perception of the nano product or its 
application (E). Finally the combination of these five analyses composes the 
Safety-Nanotec Index. Hence, this method allows a reduction in negative 
impacts and the best use of resources for nanotechnology introduction, what 
allows the prevention and mitigation of environmental damages. All activities 
related to commercial release, field trial tests, greenhouse experiments, or even 
lab assays with nano products can be evaluated by the Safety-Nanotec Method. 
Therefore, the method can be used throughout nanotechnology development, 
from the new trait search to the regulator assessment for market clearance.  
Obviously, the exchange of information and experience among all involved 
parts allows an accurate analysis of nanotechnology safety. The method can be 
used by program and project evaluators and managers, as well as by regulatory 
and supervisory agencies.  
 
Worksheets to compile the Nanotechnology Safety Assessment: the Safety 
Nanotec Index 
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The nano product assessment is composed of safety information that has been 
already obtained in a laboratory essay or from the literature (Table 1): i) raw 
material safety data; ii) stability tests of the new product, iii) stability tests of 
the new feature, iv) evaluation of agronomic applications, v) innocuity tests of 
the new product (aimed at pharmaceutical or cosmetic products); vi) food 
safety tests (substantial equivalence), vii) non-toxic ingredients. 
 
 
Each weight given to moderation factors will be considered for the 
generation of the Safetyassess index, according to the formula below (Tables 2, 3, 
4 and 5): 
 
Safety test (A) + Residual characterization and destination (B) + Toxicology 
characteristics or assessment of the nano-product (C) + Characteristics of the 
nano-product (D) + Risk perception (E) = Safety Nanotec Index 
 
Tiers of Nanotechnology Safety Index built with the technical impact value 
 
The second tool provides a structure to observe the result of the safety 
assessment of the nano product (Figure 1). After the tier 1 - safety assessment, 
the identification of characteristics and impact assessment of the nano product 
are proceed as tier 2. The safety analysis of its related effects is the final step of 
the assessment process that consists of reviewing the potential effect and 
establishing at which level the safety management must take preventive or 
corrective actions in order to allow an effective and safe use of the nano 
product.  
Figure 1 shows the classes of the Safety Nanotec Index. The illustration of 
the results of the assessment by dimension (with letters representing each 
dimension) allows formulating a list of recommendations, aiming at optimizing 
the nanotechnology safety on each analysis. The level of performance of the 
technology under evaluation is classified as follows:  
(1) Safety assessment: very unfavorable safety evaluation of the 
nanotechnology – the nano product is not recommended.  
(2) Safety assessment: favorable safety evaluation of the nanotechnology – 
the nano product is recommended.  
(3) Safety assessment: very favorable safety evaluation of the 
nanotechnology - the nano product is highly recommended. 
 
Conclusion 
 
This rapid appraisal allows us to define preventive measures to mitigate or 
avoid adverse effects or unexpected occurrences from potential or identified 
hazards. Thus, it is possible to develop and release a nanotechnology with a 
high probability of success and safety. 
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The safety assessment proposed here includes parameters that allow 
estimating the effects of the nanotechnology release in the environment or in 
human or animal health based on the assignment of quantitative values to 
several factors correlated with the impact. It results in lower subjectivity and 
higher clarity in the analysis. Technologies with the same objectives can also 
be compared using the proposed Method. 
Considering the wide variety of nanotechnology products and studies in 
different development phases to be evaluated, safety concerns must be 
addressed on a case-by-case basis. The proposed Method may not cover all 
issues, but it presents a broad approach to safety assessment. There might be 
always a new and better method that could be used, hence the user is 
encouraged to expand the possibilities of this tool by adding or deleting 
indicators according to the kind of technology addressed. Moreover, investors 
and regulators can evaluate whether the chosen parameters are the best to 
define the potential impact of the nano product under analysis. 
This strategy is very important to a less superficial method that is able to 
identify which parameters are more strongly correlated with nanotechnology or 
nanoscience. In addition, characterizing the impact by measuring it with 
quantitative tools reduces subjectivity drastically. The proposed method 
represents a less subjective and clearer process for impact assessment than 
other current processes. 
In a nutshell, some efforts from research institutions or governmental 
agencies could be addressed to define the criteria to develop safety assessment 
protocols (in a general or a specific way). 
The accuracy of the evaluation provided by this methodology results in 
preliminary technical information that could be the basis to guide the protocol 
that will contribute for the discussion of a standard regulation process that will 
guide the rational release and laboratory development of this technology. 
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Table 1. Safety data of the nano product (A) 
Data / tests 
Occurrence 
Stage of 
development Results 
Initial (1) 
Yes 
1 
No 
0 
Advanced (2) Favorable (+1) 
Conclusive (3) Unfavorable (-
1) Not studied (0) 
i) raw material safety data / tests    
ii) stability tests of the new 
product 
   
iii) stability tests of the new 
feature 
   
iv) evaluation of agronomic 
applications 
   
v) innocuity tests of the new 
product (aimed at pharmaceutical 
or cosmetic products) 
   
vi) food safety tests (substantial 
equivalence) 
   
vii) non-toxic ingredients    
 
Table 2. Residual characterization and destination (B) 
Residual characterization of the nano product Yes No 
Conventional or inert residues of the nano product or nanoscale 
substances 
0 -1 
Nanoparticle residues of the nano product -2 0 
Localization of the site where the nanotechnological residue 
will be released 
Yes No 
Appropriate destination for the nanoparticle residues 1 -1 
Non-specific destination or release of nanoparticle residues -2 0 
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Table 3. Toxicological characteristics of the nano product (C) 
Ecotoxicological characteristics of the raw material Weight 
Platinum nanoparticles -3 
Metal oxides components in the nano product development -2 
Intermediary group or non-metal component in the development 1 
Toxicology assessment of the nano product Weight 
Negative evaluation in vivo tests (birds, aquatic organisms, etc.) -3 
Negative evaluation in vitro tests -2 
The toxicology result corroborates a toxicological description in the 
literature 
-1 
The toxicology result is equivalent to an alternative or substitute 
technology product 
0 
Positive or inert toxicology result in comparison with alternative or 
substitute technology product 
+1 
Abiotic factors Weight 
pH alteration -1 
Water salinity influence -1 
Interaction with other compounds -2 
 
Table 4. Nano product characteristics (D) 
Nano product structure  More than…* Less than…* 
Superficial area of the final nano product -1 0 
Amount of nano product aggregate or spread -1 0 
Size of the nanoparticles or their components -1 (<40nm) 0 (>40nm) 
Nano product characteristics Yes No 
Unknown chemical properties of the nanoparticles 
or their residues  
-1 0 
Adsorption in the surface or in the organisms -2 0 
Solubility  -1 +1 
Stability of the nanoparticles +1 -1 
Photocatalysis -1 +1 
Degradation/biodegradation (Inactivation) +1 -1 
*Result in comparison with the non-nanoparticles component / material. 
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Table 5. Risk perception of the nano product or its application (E) 
Risk perception of the nano product or its application Weight 
Null risk perception (no kind of sues perpetrated against similar 
technology) 
0 
Unfavorable risk perception  -2 
Benefit perception tested in groups of interest associated with 
technology use 
+2 
 
Figure 1. The Index of the technical assessment is the final step of the 
Nanotechnology Safety Assessment. In this figure the row represents the three 
classes of the Safety Index. 
1 2 3 
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